Table I.
Baseline Characteristics
| Stenting (n=17) | Stenting/DEP (n=31) | P Valuea | |
|---|---|---|---|
| Age, y | 69±7 | 75±6 | .005 |
| Male | 12 (71) | 22 (71) | NS |
| White | 17 (100) | 28 (90) | NS |
| Hypertension | 17 (100) | 31 (100) | NS |
| Diabetes | 8 (47) | 9 (29) | NS |
| CAD | 11 (65) | 21 (67) | NS |
| CVA | 4 (24) | 4 (13) | NS |
| PAD | 9 (53) | 14 (45) | NS |
| Hyperlipidemia | 13 (76) | 20 (65) | NS |
| CHF (EF <50%) | 2 (12) | 7 (23) | NS |
| CHF (EF >50%) | 1 (6) | 0 (0) | NS |
| eGFR | 37±15 | 34±13 | .47 |
| SBP | 161±26 | 152±21 | .18 |
| DBP | 82±12 | 73±13 | .02 |
| No. of meds | 3.1±0.8 | 3.2±1.0 | .87 |
Abbreviations: CAD, coronary artery disease; CHF, congestive heart failure; CVA, cerebrovascular accident; DEP, distal embolic protection; DBP, diastolic blood pressure; EF, ejection fraction; eGFR, estimated glomerular filtration rate; PAD, peripheral arterial disease; SBP, systolic blood pressure. Values are expressed as No. (%) or mean ± SD. a P<.05, significant.